Skip to content
TheBias Brief

Fox NewsSig. 5NewsTradeEconomyForeign

Bessent reveals extension to Busan agreement with China until January

Treasury Secretary Scott Bessent announced on Fox News that the U.S. and China agreed to extend their Busan trade truce until January 10, giving both sides more time to negotiate economic issues. The segment also touched on Iran and AI.

Washington ExaminerSig. 6NewsTradeEconomyPolitics

Trump says US is negotiating fertilizer deal with Belarus

President Trump announced the US is negotiating a deal to buy potash fertilizer from Belarus as a trade war with Canada raises costs for farmers and ranchers. The report notes political pressure ahead of the midterms and prior administration steps to ease agricultural prices.

Right 1.7

Washington ExaminerSig. 6OpinionHealthEconomyTrade

Trump’s drug price plan targets foreign freeloaders — but shoots American innovators

An op-ed argues that the Trump administration’s GLOBE and GUARD Medicare pilot programs, meant to stop foreign free-riding on U.S. drug prices, would instead penalize small and mid-size American biotech firms. Because those firms often out-license foreign marketing rights, the piece says they cannot control foreign pricing and would bear costs they cannot recover, potentially reducing innovation and patient access. It urges the administration to confront foreign governments directly rather than penalize U.S. innovators.

Right 3.9

The HillSig. 8OpinionForeignTradeDefense

Beware Beijing bearing gifts as Xi visits America’s dealmaker-in-chief

An opinion piece warns that Xi Jinping's Washington visit comes amid China's deep commercial penetration of U.S. infrastructure and key industries, arguing trade must be viewed through national security and enforcement lenses. It credits the Trump administration with accelerating a shift from decades of permissive trade policy to stricter scrutiny, while acknowledging the two economies remain intertwined.

Right 3.3

Fox NewsSig. 5OpinionHealthEconomyTrade

If Trump wants to lower drug prices, his obvious free-riding targets are outside the US

This opinion piece argues that Trump's new drug pricing agreements are commendable but insufficient because the root cause of high U.S. drug prices is foreign governments free-riding on American pharmaceutical innovation. It urges the administration to target foreign price controls and rebate policies so other wealthy nations pay more for medicines.

Right 3.6

Washington ExaminerSig. 6AnalysisEconomyPoliticsTrade

Vance and the GOP’s Hamiltonian turn

The article examines Vice President JD Vance's embrace of Hamiltonian economics over Friedman-style free markets, tracing his tariff defenses and religious framing. It argues Vance has reversed earlier free-trade positions and that economists and tariff tracking undermine his approach.

Right 3.8

Wall Street JournalSig. 4OpinionEnergyEconomyTrade

Opinion | To Wean Off China, Build Domestic Batteries

The opinion argues that U.S. battery independence requires domestic capability across materials, technology, and manufacturing because China dominates every stage of lithium-ion production. It asks how Washington will help American companies build competitive alternatives after criticizing Ford's Chinese battery partnerships.

Right 2.0